Related Experiment Video

Updated: May 15, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Rifampicin-induced lupus erythematosus

Ting-Hui Li, Xiao-Bin Hou, Jian-Min Chang

    The Journal of Dermatology
    |January 9, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
    09:43

    Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

    Published on: June 8, 2022

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
    12:04

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

    Published on: November 1, 2015

    Related Experiment Videos

    Last Updated: May 15, 2026

    System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
    09:57

    System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

    Published on: April 5, 2017

    Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
    09:43

    Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

    Published on: June 8, 2022

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
    12:04

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

    Published on: November 1, 2015

    Related Concept Videos

    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Drug Toxicity: Allergic Reactions01:30

    Drug Toxicity: Allergic Reactions

    Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

    Articles linked to this work by shared authors, journal, and citation graph.

    Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis.

    Lung cancer (Amsterdam, Netherlands)·2026

    Glucose substrate in the hydrogen breath test for gut microbiota determination: A recommended noninvasive test.

    World journal of clinical cases·2022

    [Established Genital and Extragenital Lichen Sclerosus:A Clinicopathological Analysis].

    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae·2022

    Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma.

    World journal of clinical cases·2021

    Diffuse Neurofibroma: An Uncommon Cause of Alopecia.

    Skin appendage disorders·2020

    Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.

    FEBS open bio·2019

    Systemic Treatment of Psoriasis: Current Evidence on Efficacy and Safety.

    The Journal of dermatology·2026

    Treatment of Vulvar Lichen Sclerosus With Topical Ruxolitinib: A Single-Center Study.

    The Journal of dermatology·2026

    A Prediction Model for the Differential Diagnosis of Bowen's Disease and Bowenoid Actinic Keratosis.

    The Journal of dermatology·2026

    Risk and Impact of Cytomegalovirus Infection in Bullous Pemphigoid Patients Treated With Immunosuppressive Agents.

    The Journal of dermatology·2026

    Real-World Effectiveness, Treatment Course, and Safety of Tapinarof Cream 1% for Atopic Dermatitis and Plaque Psoriasis in Japan.

    The Journal of dermatology·2026

    Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5-Year Analysis of the Phase 3 POETYK PSO-1, PSO-4, and Long-Term Extension Trials.

    The Journal of dermatology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us